Company Background:
Bioalpha Holdings Berhad (BHB) (Stock Code: 0179) is principally involved in the manufacturing and sale of semi-finished and finished health supplement products, as an ODM, as well as under the Company’s proprietary house brands.
Its health supplement products comprise processed herbs, formulated ingredients, functional foods as well as herbal and non-herbal supplements which offer a variety of health benefits including detoxification, immune system health, blood glucose regulation and brain health, as well as beauty benefits such as weight management and anti-aging.
See company website for more information:
http://www.bioa.com.my/
The company is currently in expansion mode and expanding downstream into retail pharmacy operations.
Being a relatively newly listed company, the stock does not have much coverage but the long-term prospects look good. One research report by CIMB recently gives a target price of 65 sen. See attached:
CIMB research report on BioAlpha
Market Action:
6 May 2016 Bought Bioalpha at 35.5 sen
9 May 2016 Bought Bioalpha at 36 sen
No comments:
Post a Comment